Health
FDA Approves GSK’s Hibsago, the First ‘Functional Cure’ for Chronic Hepatitis B
The FDA has approved GSK's Hibsago (bepirovirsen), the first antisense therapy for chronic hepatitis B — offering 19%…
The FDA has approved GSK's Hibsago (bepirovirsen), the first antisense therapy for chronic hepatitis B — offering 19%…